{
  "url": "https://openlegislation.uk/eu-directive-1996-22/article-4",
  "json_url": "https://openlegislation.uk/eu-directive-1996-22/article-4.json",
  "legislation": "eudr/1996/22",
  "legislation_title": "Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC",
  "legislation_url": "https://openlegislation.uk/eu-directive-1996-22",
  "path": "article/4",
  "kind": "article",
  "number": "4",
  "heading": null,
  "text": "Notwithstanding Articles 2 and 3, Member States may authorize:\n1.. the administering to farm animals, for therapeutic purposes, of oestradiol 17 β , testosterone and progesterone and derivatives which readily yield the parent compound on hydrolysis after absorption at the site of application. Veterinary medicinal products used for therapeutic treatment must comply with the requirements for placing on the market laid down in Directive 81/851/EEC and be administered only by a veterinarian, by injection or for the treatment of ovarian dysfunction in the form of vaginal spirals, but not by implant, to farm animals which have been clearly identified. Treatment of identified animals must be registered by the veterinarian responsible. The latter must record at least the following details in a register, which may be the one provided for in Directive 81/851/EEC:\ntype of treatment,\nthe type of products authorized,\nthe date of treatment,\nthe identity of the animals treated.\nThe register must be made available to the competent authority at its request;\n2.. the administering for therapeutic purposes of authorized veterinary medicinal products containing:\n(i) allyl trenbolone, administered orally, or beta-agonists to equidae, provided they are used in accordance with the manufacturer’s instructions;\n(ii) beta-agonists, in the form of an injection to induce tocolysis in cows when calving.\nSuch substances must be administered by a veterinarian or, in the case of the veterinary medicinal products referred to in (i), under his direct responsibility; treatment must be registered by the veterinarian responsible, who shall record at least the details referred to in point 1.\nFarmers shall be prohibited from holding veterinary medicinal products containing beta-agonists which may be used for induction purposes in the treatment of tocolysis.\nHowever, without prejudice to the first subparagraph of point 2 (ii), therapeutic treatment of production animals, including breeding animals at the end of their reproductive life, shall be prohibited.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Deleted by Directive 2003/74/EC of the European Parliament and of the Council of 22 September 2003 amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists."
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Substituted by Directive 2008/97/EC of the European Parliament and of the Council of 19 November 2008 amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists (Text with EEA relevance)."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/1996/22/article/4",
    "retrieved_at": "2026-11-01T15:23:13.165595+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}